Co-Diagnostics, Inc.
(Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ COVID-19 Test Kit was used by Australian researchers to demonstrate rapidly deployable mobile molecular diagnostics support for remote locations, with the peer-reviewed results published in the
Journal of Medical Microbiology.
The study was performed using readily available open-source equipment and materials that could be successfully operated in regional clinical laboratories, many of which are not currently equipped for molecular diagnostics. When tested on clinical samples, the sensitivity and specificity of the Company s test showed complete concordance with the comparison assay used in the study. The researchers also demonstrated an analytical sensitivity of 1010 viral copies per milliliter, which they found to be comparable to other tests used across Western Australia.
Tabula Rasa HealthCare First Quarter 2021 Earnings Conference Call Announcement
News provided by
Share this article
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
, will hold a conference call and webcast to discuss its first quarter 2021 operating results on
Friday, May 7, 2021 at 8:30 a.m. EDT. The conference call will be hosted by TRHC CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; TRHC Co-Founder and President, Orsula V. Knowlton, PharmD; and TRHC Chief Financial Officer, Brian W. Adams. The Company s financial results for the first quarter 2021 will be released after the close of the market on
Thursday, May 6, 2021.
For a live audio webcast of the call, please visit the investor relations section of TRHC s website (ir.trhc.com). To listen to the conference call please dial 844-413-0947, or 216-562-0423 for international callers, and reference passcode 2849587 approximately 15 minutes prior to the call.
iHerb Opens Its Sixth Fulfillment Center in Hong Kong
USA - English
Share this article
Share this article
PASADENA, Calif., April 20, 2021 /PRNewswire/ iHerb is pleased to announce the opening of its sixth fulfillment center. Located in Hong Kong, it will be the company s second overseas and will serve China, Hong Kong, Japan, Malaysia, Singapore, and Thailand. The fulfillment center will carry up to 6,000 of iHerb s top-selling products, improving delivery speed for customers favorite items to as early as the next day if the order is placed prior to 1:00 PM Hong Kong time.
The Hong Kong fulfillment center is established in partnership with DB Schenker, responsible for full-spectrum warehouse management services. Equipped with a state-of-the-art AGV robotic solution that will increase the efficiency of pick operations, the fulfillment center is expected to process up to 20,000 orders per day.
Share this article
Share this article
NEW BRUNSWICK, N.J., April 20, 2021 /PRNewswire/ Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 5.0% increase in the quarterly dividend, from $1.01 per share to $1.06 per share. Despite a year of unprecedented disruption, Johnson & Johnson remained committed to its established financial principles that strengthen our ability to drive long-term value for stakeholders. In recognition of our notable 2020 results, strong financial position and confidence in the future of Johnson & Johnson, the Board of Directors has voted to increase the quarterly dividend for the 59th consecutive year, said Alex Gorsky, Chairman and Chief Executive Officer of the company.
Share this article
Share this article
DENVER, April 20, 2021 /PRNewswire/ CereHealth Corp., a data analytics technology company that provides Medical Analytics as a Service, announced today the addition of James Chomas, Ph.D. as the company s Chief Executive Officer. Dr. Chomas will work closely with John Kelley, who has served as CereHealth s CEO since 2009 and driven the company s evolution from a single site brain imaging clinic to a nationwide neurodiagnostic network and leader in advanced CNS data analytics and technologies. Mr. Kelley will transition to the role of Executive Director and continue serving as Chair of the Board. He will continue to have direct involvement in the company s strategies to bring its browser-based, cloud-enabled imaging and data analytics platforms, CereMetrixAi™ and iLLUMEAi, to a global market.